Skip to content

Phoenix Life Sciences International Limited.: 10-Q filed 2019-04-25

What Phoenix Life Sciences International Limited. reported in its quarterly report filed 2019-04-25 (fiscal Q2 2019): 15 published measures, 40 facts as tagged in accession 0001387131-19-002919.

This filing

Form
10-Q (quarterly report)
Filed
2019-04-25
Fiscal period
fiscal Q2 2019
Accession
0001387131-19-002919 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Phoenix Life Sciences International Limited. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-08-31236,404USD
At 2018-02-28236,449USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-08-311,899,406USD
At 2018-02-281,601,119USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-08-31-1,663,002USD
At 2018-02-28-1,364,670USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-06-01 to 2018-08-31-294,429USD92
2018-03-01 to 2018-08-31-434,864USD184
2017-06-01 to 2017-08-313,134USD92
2017-03-01 to 2017-08-31187,443USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-08-31-19,585,203USD
At 2018-02-28-19,150,339USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-03-01 to 2018-08-31131,249USD184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-03-01 to 2018-08-31-45USD184
2017-06-01 to 2017-08-31-109USD92
2017-03-01 to 2017-08-31-376USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-08-31236,404USD
At 2018-02-28236,449USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2018-06-01 to 2018-08-3125,416USD92
2018-03-01 to 2018-08-3149,442USD184
2017-06-01 to 2017-08-3120,336USD92
2017-03-01 to 2017-08-3139,560USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-08-311,899,406USD
At 2018-02-28795,529USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-03-01 to 2018-08-3145USD184
2017-06-01 to 2017-08-31109USD92
2017-03-01 to 2017-08-31376USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-08-3147,571shares
At 2018-02-2834,171shares
At 2017-02-2831,067shares
At 2015-10-2250,125shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-08-3117,921,854USD
At 2018-02-2817,785,335USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-03-01 to 2018-08-3145USD184
2017-06-01 to 2017-08-31109USD92
2017-03-01 to 2017-08-31376USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2018-06-01 to 2018-08-31-294,429USD92
2018-03-01 to 2018-08-31-434,819USD184
2017-06-01 to 2017-08-313,243USD92
2017-03-01 to 2017-08-31187,819USD184

Inspect the source

Entity
Phoenix Life Sciences International Limited. / CIK 0001493212
Captured
SEC response SHA-256
e9e4eff3c476f5eb033bab91a133e7dfeaf63cfa51c8097afeedbc2cb284bfb3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001493212.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))